American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

Recruiting now

Conditions studied: Pancreatic Cancer

In brief

The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions. The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.

Key facts

Study ID

NCT02674100

Run by

University of Louisville

People needed

500

Starts

2016-01-01

Expected to finish

2030-01-01

Last updated by the study team

2025-02-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (greater than 18 years of age) diagnosed with pancreatic cancer that are eligible for soft tissue ablation per the treating physician.

You may not qualify if…

• Have a cardiac pacemaker or ICD implant
• Non-removable implants with metal parts near target lesion
• Myocardial infarction within 3 months prior to enrollment
• Not suitable for general endotracheal anesthesia

Where it is running

• University of Alabama Birmingham — Birmingham, Alabama, United States (enrolling)
• University of California San Diego — San Diego, California, United States (enrolling)
• University of Colorado — Denver, Colorado, United States (enrolling)
• University of South Florida — Tampa, Florida, United States (enrolling)
• Augusta University — Augusta, Georgia, United States (enrolling)
• University of Louisville — Louisville, Kentucky, United States (enrolling)
• Johns Hopkins Hospital — Baltimore, Maryland, United States (enrolling)
• Atlantic Health — Millburn, New Jersey, United States (enrolling)
• Northwell Health Cancer Institute — Lake Success, New York, United States (enrolling)
• Gibbs Cancer Research, Spartanburg Regional Healthcare System — Spartanburg, South Carolina, United States (enrolling)
• Methodist Digestive Institute — Dallas, Texas, United States (enrolling)
• McGill University — Montreal, Quebec, Canada (enrolling)
• Sanno Hospital — Tokyo, Japan, Japan (enrolling)
• Centro Medico — Mexico City, Mexico (enrolling)
• National Taiwan University — Taipei, Taiwan (enrolling)
• Freeman Hospital — High Heaton, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.